Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes

https://mct.aacrjournals.org/content/early/2019/08/13/1535-7163.MCT-18-1386

ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors

https://www.thno.org/v10p0151.htm

Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486173/

A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer

http://clincancerres.aacrjournals.org/content/25/1/166

GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance

https://elifesciences.org/articles/41913

Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer

https://pubmed.ncbi.nlm.nih.gov/28891793/

SOX2 promotes lineage plasticity and antiandrogen resistance in TP53– and RB1-deficient prostate cancer

https://science.sciencemag.org/content/355/6320/84.full

Abstract B38: Tetravalent bispecific antibodies specific for HER2 and disialoganglioside GD2 to engage polyclonal T cells for osteosarcoma therapy

https://cancerres.aacrjournals.org/content/78/19_Supplement/B38

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction.

https://www.jove.com/video/59041/pretargeted-radioimmunotherapy-based-on-inverse-electron-demand-diels

A rectal cancer model establishes a platform to study individual responses to chemoradiation

https://www.nature.com/articles/s41591-019-0584-2

A potent tetravalent T-cell–engaging bispecific antibody against CD33 in acute myeloid leukemia

https://www.ncbi.nlm.nih.gov/pubmed/29858209

Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model

https://link.springer.com/article/10.1007/s11307-018-1177-z

Development of a tetravalent anti-GPA33/anti-CD3 bispecific antibody for colorectal cancers

https://europepmc.org/article/PMC/6168351

FOXA1 mutations alter pioneering activity, differentiation, and prostate cancer phenotypes

https://escholarship.org/uc/item/5jq9v28q

Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies

https://stm.sciencemag.org/content/12/534/eaax1315.full